Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

Authors

Priya Bahri, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Geoffrey Bowring, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Brian D. Edwards, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Christopher Anton, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Jeffrey K. Aronson, University of Oxford Medical Sciences Division
Angela Caro-Rojas, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Bruce P.J. Hugman
Peter G. Mol, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Gianluca Trifirò, Università degli Studi di Verona
Katarina Ilic, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Riadh Daghfous, Centre National de Pharmacovigilance
Irene Fermont, Israel Society for Medication and Vaccine Safety (ERANIM)
Giovanni Furlan, Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Wolfgang Gaissmaier, Universität Konstanz
Mohammad Ishaq Geer, University of Kashmir
Kenneth Hartigan-Go, Ateneo School of GovernmentFollow
François Houÿez, European Organisation for Rare Diseases (EURORDIS)
Hansjörg Neth, Universität Konstanz
Gediminas Norgela, Uppsala Monitoring Centre
Yaowares Oppamayun, The Food and Drug Administration, Thailand Ministry of Public Health
D. K.Theo Raynor, University of Leeds

Document Type

Article

Publication Date

6-1-2023

Recommended Citation

Bahri, P., Bowring, G., Edwards, B.D. et al. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance. Drug Saf 46, 517–532 (2023). https://doi.org/10.1007/s40264-023-01285-5